[Trial of danazol and zidovudine combination in HIV infection. Increased risk of cutaneous allergy].
Lang
J M
JM
Dossou-Gbete
V
V
De Mautort
E
E
Zorn
A
A
Steckmeyer
M
M
D000386:AIDS-Related Complex / Q000188:drug therapy*; D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D000328:Adult; D002986:Clinical Trials as Topic; D003613:Danazol / Q000008:administration & dosage* / Q000009:adverse effects; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D010865:Pilot Projects; D011245:Pregnadienes / Q000008:administration & dosage*; D015215:Zidovudine / Q000008:administration & dosage*
D011245:Pregnadienes; D015215:Zidovudine; D003613:Danazol
Essai d'association du danazol à la zidovudine dans l'infection par le VIH. Risque élevé d'allergie cutanée.